InvestorsHub Logo
Followers 37
Posts 4190
Boards Moderated 0
Alias Born 10/18/2016

Re: None

Monday, 03/20/2017 1:20:15 PM

Monday, March 20, 2017 1:20:15 PM

Post# of 9219
Compensated Awareness Post View Disclaimer
Leadership Team

Management

PRESIDENT, CHIEF EXECUTIVE OFFICER, AND DIRECTOR
Ram Mukunda

Mr. Ram Mukunda, has served as our Executive Chairman, Chief Executive Officer, and President since our inception on April 29, 2005.

From January 1990 to May 2004, Mr. Mukunda served as founder, Chairman, and Chief Executive Officer of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec was the first pure play international long distance carrier. Mr. Mukunda was responsible for organizing, structuring, and integrating a number of companies owned by Startec. Under Mr. Mukunda’s tenure at Startec, the company made an initial public offering of its equity securities in 1997 on NASDAQ. Prior to Startec, Mr. Mukunda served as Strategic Planning Advisor at Intelsat, a communications satellite services provider.

Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs.

Mr. Mukunda is the recipient of several awards including, among others, the 2013 University of Maryland’s International Alumnus of the year award, the 2001 Distinguished Engineering Alumnus Award, the 1998 Ernst & Young, LLP’s Entrepreneur of the Year Award. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.

--

CFO, Treasurer, PAO
John Cherin

Mr. John Cherin is a retired senior executive with international experience in assisting young companies. He has provided insight to top management and Board of Directors on strategic analysis and improvement of operating procedures in financial reporting and operations. From 1966 to 1997, Mr. Cherin gained his experience as a senior partner at Arthur Andersen while managing practices aimed at businesses in the US and overseas. In addition he founded and managed Cherin Global Consulting in 1997-2005 and the Cherin Group LLC in 2004 to date. He also served as CFO for IGC in its formative stages for the purpose of raising capital to enable IGC's launch in the post startup phase.

Mr. Cherin is a retired CPA, a graduate of Northeastern University class of 1966 and in 1967 was the Silver Medal Recipient from the Massachusetts Society of CPAs.

--

GENERAL MANAGER, DIRECTOR OF CABARAN ULTIMA
Claudia Grimaldi

Ms. Claudia Grimaldi is the General Manager and Director of our project development and managing company in Malaysia. Ms. Grimaldi is responsible for coordinating the staff in various countries and ensuring timely and accurate regulatory compliance and statutory reporting. Prior to assuming her current role in 2013, she spent three years managing the office of the CEO.

Prior to IGC, Ms. Grimaldi worked in human resources and psychotherapy. Ms. Grimaldi graduated Summa Cum Laude from Javeriana University, a top five University in Colombia, with a Bachelor of Arts in Psychology. She holds an MBA in General Management, graduating with Highest Honors, from Meredith College. She is a member of Delta Mu Delta International Honor Society. She is also fluent in both English and Spanish.

---- ---- ---- ---- ---- ----

Senior Advisors

Dr. Ranga Krishna is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. In February 2003, Dr. Krishna founded International Pharma Trials, Inc., a company with over 150 employees, which assists U.S. pharmaceutical companies performing Phase II clinical trials. Dr. Krishna is the Medical Director and Chairman of Total Neuro Care, PC. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College.

Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Worker's Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996).

--

Dr. James A. Saunders is an advisor to the Company in plant genomics, natural product plant biochemistry, gene transfer, extraction technologies, hybridization, and DNA finger printing, among other areas.

He has published 95 peer-reviewed manuscripts and has made over 280 scholarly presentations in national and international forums. Between 1977 and 2003 Dr. Saunders served as a Plant Biochemist with the United States Dept. of Agriculture in Beltsville Maryland, in the Tobacco Laboratory and Drug Crops Laboratory, among other assignments focusing on the chemistry and medicinal effects of secondary natural plant products especially those found in Tobacco, Cannabis, Opium Poppy, Coca and Chocolate crops. Between 2004 and 2011, Dr. Saunders was Director, Molecular Biology, Biochemistry and Bioinformatics and Professor, Department of Biological Sciences, and Department of Chemistry, at Towson University. Subsequently, he was Chairman of the Maryland Section of the American Chemical Society (2012 -2014).

Dr. Saunders received a B.A., Zoology 1971 from University of South Florida, a Ph.D., Botany, from Miami University in 1975, and a Postdoctoral Scholar and Research Biochemist, Department of Biochemistry and Biophysics, from University of California, Davis in 1977. He has taught undergraduate and graduate level science classes at Towson University, University of Maryland College Park, Stevenson University, Catholic University, Cairo University, and the NIH among other locations.

--

Dr. Anil K. Gupta has served as our Senior Advisor since May 25, 2005. Dr. Gupta has been Professor of Strategy and Organization at the University of Maryland since 1986. He has been Chair of the Ralph J. Tyser Management & Organization Department and Research Director of the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business at the University of Maryland at College Park, since July 2003. Dr. Gupta earned a Bachelor of Technology from the Indian Institute of Technology in 1970, an MBA from the Indian Institute of Management in 1972, and a Doctor of Business Administration from the Harvard Business School in 1980.

Dr. Gupta has served on the board of directors of NeoMagic Corporation (NMGC) since October 2000 and has previously served as a director of Omega Worldwide (OWWP) from October 1899 through August 2003 and Vitalink Pharmacy Services (VTK) from July 1992 through July 1999.

--

Jack Lynch is an advisor to the company in intellectual property matters. He has over 50 years experience in practice before US District and Appellate courts and the US Patent and Trademark Office. Mr. Lynch’s Juris Doctor is from Georgetown Law School and he holds a BS in chemistry from Fordham University. He was the founding partner in a New York City law firm, which merged with Fulbright & Jaworski in 1998. Mr. Lynch has taught IP law courses since 1997 at Georgetown, the University of San Francisco School of Law (as well as summer sessions at Trinity University in Dublin and Charles University in Prague) and Ave Maria School of Law.

--

Mr. Chua Seong Seng is an advisor to the Company in agro economy, building medical grade botanical oil extraction facilities, designing tissue culture labs, and constructing cultivation facilities for medicinal and resin producing plants. He is an economist by training, investment and corporate financier and serial entrepreneur by profession, with a passion for the cultivation of medicinal and oil producing plants.

He has over 20 years experience specializing in real estate, particularly in property development, and large plantation development. Mr. Seng developed, financed, and built a bio-fuels production company, and the first oil tree nursery to utilize tissue culture technology in Malaysia. The nursery was subsequently listed on the Singapore stock exchange.

Based in Malaysia, Mr. Seng manages a firm that pioneered specialized real estate development with clients from Europe, South East Asia and the Middle East. He works closely with some of the large Chinese construction companies and has close ties with the Bank of China having worked with them on structuring mega construction projects in Malaysia and other countries.

Mr. Seng received a BA (Hons) in Economics from University of Malaya, Malaysia.

---- ---- ---- ---- ---- ----

Board of Directors

Mr. Richard Prins has been our Chairman and Audit Committee Chairman since 2012, and has served as a Director since May 2007. Mr. Prins has more than 27 years of experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW). FBW was the lead underwriter for our 2006 initial public offering. FBW was sold to Royal Bank of Canada (RBC) in 2008. Mr. Prins served in a consulting role to RBC until January 2009. Mr. Prins currently serves on several boards, volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Prior to FBW, from July 1988 to March 1996, Mr. Prins was Senior Vice President and Managing Director for the Investment Banking Division of Crestar Financial Corporation (SunTrust Bank).

From 1993 to 1998, he was with the leveraged buy-out firm Tuscarora Corporation. Mr. Prins has experience serving on the boards of other publicly held companies. Since February 2003, he has been on the board of Amphastar Pharmaceuticals, Inc. and, since March 2010, he has been on the board of Hilbert Technologies. Mr. Richard Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, has extensive experience in finance, accounting, and internal controls over financial reporting. He brings important investment banking experience. Mr. Prins has traveled in India, China and Africa.

--

Mr. Sudhakar Shenoy has been our Compensation Committee Chairman since 2012, and has served as a Director since the inception of IGC in May 2005. Since January 1981, Mr. Shenoy has been the Founder, Chairman, and Chief Executive Officer of Information Management Consulting, Inc., a business solutions and technology provider with operations in the United States and India. Mr. Shenoy was a member of the Non-Resident Indian Advisory Group that advised the former Prime Minister of India on strategies for attracting foreign direct investment. Mr. Shenoy was selected for the U.S. Presidential Trade and Development Mission to India in 1995. In 1996, Mr. Shenoy was inducted into the Alumni Hall of Fame at the University of Connecticut School of Business and was recognized as a Distinguished Alumnus of the Indian Institute of Technology (IIT) in Bombay, India in 1997.

Mr. Shenoy was recently named Top 25 Most Influential People in Washington, D.C. high tech industry as well as being awarded the 2004 Executive of the Year by the Northern Virginia Government Contractors Council. Mr. Shenoy holds a B. Tech (Hons.) in electrical engineering from the Indian Institute of Technology and an M.S. in Electrical Engineering and an M.B.A. from the University of Connecticut Schools of Engineering and Business Administration, respectively.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGC News